Multi-centre, international, randomised, vehicle controlled, parallel-group, double-blinded Phase 2 trial of BB2603 topical treatment in subjects with distal subungual onychomycosis (DSO) of the toenail (BBTAF202).
Europe (Germany, Poland, Czech Republic)
Completed
Early phase development, partly blinded, positive and vehicle controlled, randomised, non-inferiority investigation of the pharmacokinetics, safety and efficacy of BB2603 cutaneous hand-pump spray versus Lamisil® spray and versus BB2603 vehicle hand-pump spray in subjects with onychomycosis and associated tinea pedis (BBT120126032001).
